Related references
Note: Only part of the references are listed.Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty The FOXTROT Randomized Clinical Trial
Jeffrey I. Weitz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Combination Antiplatelet and Oral Anticoagulant Therapy in Patients With Coronary and Peripheral Artery Disease Focus on the COMPASS Trial
Paul A. Gurbel et al.
CIRCULATION (2019)
Bleeding in patients receiving non-vitamin K oral anticoagulants: clinical trial evidence
Arthur Bracey et al.
THERAPEUTIC ADVANCES IN CARDIOVASCULAR DISEASE (2018)
Factor XI deficiency is associated with lower risk for cardiovascular and venous thromboembolism events
Meir Preis et al.
BLOOD (2017)
Antiplatelet and Anticoagulant Therapies for Prevention of Ischemic Stroke
Nikhil Kapil et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2017)
Coagulation factor and protease pathways in thrombosis and cardiovascular disease
Hugo ten Cate et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Factor XI as a Therapeutic Target
David Gailani et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
Updates on Acute Coronary Syndrome
Alon Eisen et al.
JAMA CARDIOLOGY (2016)
Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis
Ophira Salomon et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Coagulation factor XI as a novel target for antithrombotic treatment
E. C. Lowenberg et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Factor XI deficiency in humans
U. Seligsohn
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Reduced incidence of ischemic stroke in patients with severe factor XI deficiency
Ophira Salomon et al.
BLOOD (2008)
Inherited factor XI deficiency: A concise review
Massimo Franchini et al.
HEMATOLOGY (2006)
Elevated factor XI activity levels are associated with an increased odds ratio for cerebrovascular events
David T. Yang et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2006)
Effects of factor XI deficiency on ferric chloride-induced vena cava thrombosis in mice
X. Wang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Elevated levels of Factor XI are associated with cardiovascular disease in women
JI Berliner et al.
THROMBOSIS RESEARCH (2002)
Elevated levels of plasma prekallikrein, high molecular weight kininogen and factor XI in coronary heart disease
C Merlo et al.
ATHEROSCLEROSIS (2002)
High levels of coagulation factor XI as a risk factor for venous thrombosis.
JCM Meijers et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
